These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8274197)
1. Structural compartmentalization of MHC class II signaling function. Wade WF; Davoust J; Salamero J; André P; Watts TH; Cambier JC Immunol Today; 1993 Nov; 14(11):539-46. PubMed ID: 8274197 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells. St Pierre Y; Watts TH J Immunol; 1991 Nov; 147(9):2875-82. PubMed ID: 1680921 [TBL] [Abstract][Full Text] [Related]
3. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding. Lee JM; McKean DJ; Watts TH J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939 [TBL] [Abstract][Full Text] [Related]
4. The molecular basis of class II MHC allelic control of T cell responses. Racioppi L; Ronchese F; Schwartz RH; Germain RN J Immunol; 1991 Dec; 147(11):3718-27. PubMed ID: 1658150 [TBL] [Abstract][Full Text] [Related]
5. Length and sequence requirements of the cytoplasmic domain of the A beta molecule for class II-mediated B cell signaling. Harton JA; Bishop GA J Immunol; 1993 Nov; 151(10):5282-9. PubMed ID: 8228224 [TBL] [Abstract][Full Text] [Related]
6. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice. Agrawal B; Manickasundari M; Fraga E; Singh B J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218 [TBL] [Abstract][Full Text] [Related]
7. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex. Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414 [TBL] [Abstract][Full Text] [Related]
8. T cell recognition of self and altered self antigens. Nicholson LB; Kuchroo VK Crit Rev Immunol; 1997; 17(5-6):449-62. PubMed ID: 9419432 [TBL] [Abstract][Full Text] [Related]
9. Permissive recognition of a mycobacterial T-cell epitope: localization of overlapping epitope core sequences recognized in association with multiple major histocompatibility complex class II I-A molecules. Harris DP; Vordermeier HM; Arya A; Moreno C; Ivanyi J Immunology; 1995 Apr; 84(4):555-61. PubMed ID: 7790029 [TBL] [Abstract][Full Text] [Related]
10. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance. Guéry JC; Sette A; Appella E; Adorini L J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867 [TBL] [Abstract][Full Text] [Related]
11. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men. Holling TM; Schooten E; van Den Elsen PJ Hum Immunol; 2004 Apr; 65(4):282-90. PubMed ID: 15120183 [TBL] [Abstract][Full Text] [Related]
12. T cell receptor/peptide/MHC molecular characterization and standardized pMHC contact sites in IMGT/3Dstructure-DB. Kaas Q; Lefranc MP In Silico Biol; 2005; 5(5-6):505-28. PubMed ID: 16268793 [TBL] [Abstract][Full Text] [Related]
13. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules. Adams S; Humphreys RE Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997 [TBL] [Abstract][Full Text] [Related]
14. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain. Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991 [TBL] [Abstract][Full Text] [Related]
15. Structurally interdependent and independent regions of allelic polymorphism in class II MHC molecules. Implications for Ia function and evolution. Braunstein NS; Germain RN; Loney K; Berkowitz N J Immunol; 1990 Sep; 145(6):1635-45. PubMed ID: 1697304 [TBL] [Abstract][Full Text] [Related]
16. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Watts C Nat Immunol; 2004 Jul; 5(7):685-92. PubMed ID: 15224094 [TBL] [Abstract][Full Text] [Related]
17. Structure and function of H-2 T (Tla) region class I MHC molecules. Teitell M; Cheroutre H; Panwala C; Holcombe H; Eghtesady P; Kronenberg M Crit Rev Immunol; 1994; 14(1):1-27. PubMed ID: 7741975 [TBL] [Abstract][Full Text] [Related]
18. Replacement of N-glycosylation sites on the MHC class II E alpha chain. Effect on thymic selection and peripheral T cell activation. Ishikawa S; Kowal C; Cole B; Thomson C; Diamond B J Immunol; 1995 May; 154(10):5023-9. PubMed ID: 7730609 [TBL] [Abstract][Full Text] [Related]
19. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells. Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821 [TBL] [Abstract][Full Text] [Related]
20. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope. Atassi MZ; Oshima M; Deitiker P Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]